Page last updated: 2024-10-22

alosetron and Disease Models, Animal

alosetron has been researched along with Disease Models, Animal in 12 studies

alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to establish a pathophysiologic model of irritable bowel syndrome, and then to evaluate the pharmaceutical efficacy of ramosetron, a potent serotonin 3 (5-HT(3)) receptor antagonist, and other anti-irritable bowel syndrome agents in this model."7.74Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. ( Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Sasamata, M; Takeuchi, A, 2007)
"The aim of this study was to establish a pathophysiologic model of irritable bowel syndrome, and then to evaluate the pharmaceutical efficacy of ramosetron, a potent serotonin 3 (5-HT(3)) receptor antagonist, and other anti-irritable bowel syndrome agents in this model."3.74Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. ( Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Sasamata, M; Takeuchi, A, 2007)
"Alosetron was also efficacious in stress-induced defecation and visceral pain models at 1 and 10 mg/kg, respectively."1.56Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron. ( Aso, K; Itomi, Y; Kawamura, T; Kojima, T; Matsumoto-Okano, S; Matsushita, K; Tanaka, T; Tsukimi, Y, 2020)
"Visceral pain was measured by visceromotor response to colorectal distension, and the effects of alosetron and duloxetine on visceral pain were investigated in SART rats."1.42Specific alteration of rhythm in temperature-stressed rats possess features of abdominal pain in IBS patients. ( Itomi, Y; Kawamura, T; Tsukimi, Y, 2015)
"Visceral hyperalgesia was observed on day 7 but not on day 4."1.38Experimental colitis alters expression of 5-HT receptors and transient receptor potential vanilloid 1 leading to visceral hypersensitivity in mice. ( Horie, S; Hosoya, T; Lo, MW; Matsumoto, K; Murayama, T; Takayama, H; Tashima, K, 2012)
"Alosetron (Lotronex) is a serotonin subtype 3 (5-HT3) receptor antagonist that alleviates symptoms of irritable bowel syndrome (IBS) in female patients."1.31Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro. ( Bush, TG; Sanders, KM; Smith, TK; Spencer, NJ; Watters, N, 2001)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's3 (25.00)29.6817
2010's6 (50.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Manning, DD2
Cioffi, CL1
Usyatinsky, A1
Fitzpatrick, K1
Masih, L2
Guo, C2
Zhang, Z2
Choo, SH2
Sikkander, MI1
Ryan, KN2
Naginskaya, J2
Hassler, C1
Dobritsa, S1
Wierschke, JD2
Earley, WG2
Butler, AS1
Brady, CA2
Barnes, NM2
Cohen, ML1
Guzzo, PR2
Newman, AS1
Itomi, Y2
Tanaka, T1
Matsushita, K1
Kawamura, T2
Kojima, T1
Aso, K1
Matsumoto-Okano, S1
Tsukimi, Y2
El-Ayache, N1
Galligan, JJ1
Morgan, B1
Matsumoto, K1
Lo, MW1
Hosoya, T1
Tashima, K1
Takayama, H1
Murayama, T1
Horie, S1
Mori, T1
Kawano, K1
Shishikura, T1
Funatsu, T1
Takeuchi, A1
Hirata, T1
Keto, Y1
Akuzawa, S1
Sasamata, M1
Rudd, JA1
Naylor, RJ1
Pappas, TN1
Mangel, AW1
Lawson, C1
Bush, TG1
Spencer, NJ1
Watters, N1
Sanders, KM1
Smith, TK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of the Duodenal Microbiome in Pediatric Functional Dyspepsia[NCT02340312]40 participants (Actual)Observational2015-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for alosetron and Disease Models, Animal

ArticleYear
Review article: evaluation of drugs in experimental gut distension models.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13 Suppl 2

    Topics: Abdominal Pain; Animals; Carbolines; Colonic Diseases, Functional; Disease Models, Animal; Dogs; Ser

1999

Other Studies

11 other studies available for alosetron and Disease Models, Animal

ArticleYear
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
    Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1

    Topics: Animals; Cell Line; Disease Models, Animal; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; M

2011
The discovery of diazepinone-based 5-HT3 receptor partial agonists.
    Bioorganic & medicinal chemistry letters, 2014, Jun-01, Volume: 24, Issue:11

    Topics: Administration, Oral; Animals; Azepines; Disease Models, Animal; Dose-Response Relationship, Drug; D

2014
Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
    Neurogastroenterology and motility, 2020, Volume: 32, Issue:5

    Topics: Adrenocorticotropic Hormone; Animals; Carbolines; Conditioning, Classical; Defecation; Disease Model

2020
5-HT
    American journal of physiology. Gastrointestinal and liver physiology, 2019, 01-01, Volume: 316, Issue:1

    Topics: Animals; Carbolines; Disease Models, Animal; Humans; Hyperalgesia; Hypersensitivity; Irritable Bowel

2019
Specific alteration of rhythm in temperature-stressed rats possess features of abdominal pain in IBS patients.
    Journal of pharmacological sciences, 2015, Volume: 129, Issue:1

    Topics: Abdominal Pain; Animals; Carbolines; Cold Temperature; Disease Models, Animal; Duloxetine Hydrochlor

2015
Drug development: A healthy pipeline.
    Nature, 2016, 05-19, Volume: 533, Issue:7603

    Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; C

2016
Experimental colitis alters expression of 5-HT receptors and transient receptor potential vanilloid 1 leading to visceral hypersensitivity in mice.
    Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:5

    Topics: Animals; Carbolines; Dextran Sulfate; Disease Models, Animal; Electromyography; Hyperalgesia; Inflam

2012
5-HT3-receptor antagonist inhibits visceral pain differently in chemical and mechanical stimuli in rats.
    Journal of pharmacological sciences, 2004, Volume: 94, Issue:1

    Topics: Animals; Carbolines; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Glycerol; Male

2004
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3

    Topics: Animals; Behavior, Animal; Benzimidazoles; Carbazoles; Carbolines; Colon; Colonic Diseases, Function

2007
Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.
    Neuropharmacology, 1994, Volume: 33, Issue:12

    Topics: Animals; Carbolines; Cisplatin; Disease Models, Animal; Emetics; Ferrets; Ondansetron; Serotonin Ant

1994
Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro.
    American journal of physiology. Gastrointestinal and liver physiology, 2001, Volume: 281, Issue:4

    Topics: Animals; Carbolines; Colon; Colonic Diseases, Functional; Disease Models, Animal; Dose-Response Rela

2001